However, inhibiting G protein-coupled receptors (GPCRs) desensitization mediated by G protein coupled receptor kinase 2 (GRK2) led to increased cAMP concentration and relieved experimental arthritis models4. Here, GRK2 is linked to arthritic joint disease.